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Abstract 
 
Aims: To quantify tau pathology of chronic traumatic encephalopathy (CTE) and 
investigate influence of dot-like lesions (DL), brain region, co-morbidity, and sporting 
career length. Methods: Densities of neurofibrillary tangles (NFT), astrocytic tangles 
(AT), DL, oligodendroglial inclusions (GI), neuropil threads (NT), vacuoles, neurons, 
and enlarged neurons (EN) were measured in tau-immunoreactive sections of upper 
cortical laminae of frontal and temporal lobe, hippocampus (HC), amygdala, and 
substantia nigra (SN) of eleven cases of CTE. Results: DL were a consistent finding 
in CTE. Densities of NFT, NT and DL were greatest in sectors CA1 and CA2 of the 
HC. Densities of AT were lower than NFT, small numbers of GI were recorded in 
temporal lobe, and low densities of vacuoles and EN were consistently present. -
amyloid containing neuritic plaques (NP) also occurred at low density. Densities of 
NFT, NT, DL, and AT were greater in sulci than gyri while vacuole density was 
greater in gyri. Principal components analysis (PCA) suggested that sporting career 
length and densities of NFT in entorhinal cortex, NT in CA2 and SN, and vacuolation 
in the DG were significant sources of variation among cases. Conclusion: DL are 
frequent in CTE suggesting affinity with argyrophilic grain disease (AGD) and 
Parkinson’s disease dementia (PD-Dem). Densities of AT in all regions and NT/DL in 
sectors CA2/4 were consistent features of CTE. The eleven cases are 
neuropathologically heterogeneous which may result from genetic diversity, and 
variation in anatomical pathways subjected to trauma. 
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List of abbreviations: 
 
AD   Alzheimer’s disease 
ADNC  Alzheimer’s disease neuropathologic change 
AGD   Argyrophilic grain disease 
ANOVA Analysis of variance 
AT   Astrocytic tangle 
CBD   Corticobasal degeneration 
CTE   Chronic traumatic encephalopathy 
DG   Dentate gyrus 
DL   Dot-like lesions 
EC   Entorhinal cortex 
EN   Enlarged neuron 
HC   Hippocampus 
HS   Hippocampal sclerosis 
GI    Oligodendroglial inclusion 
NFL   National football league 
NFT   Neurofibrillary tangle 
NIA-AA National Institute on Aging-Alzheimer’s Association 
NP   Neuritic plaque 
NT   Neuropil thread 
PART  Primary age-related tauopathy 
PCA   Principal components analysis 
PD-Dem Parkinson’s disease dementia 
PiD   Pick’s disease 
PSP   Progressive supranuclear palsy 
SFG   Superior frontal gyrus 
SN   Substantia nigra 
STG   Superior temporal gyrus 
TDP-43  Transactive response DNA-binding protein of 43kDa 
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Introduction 
 
Mortality from neurodegenerative disease, including Alzheimer’s disease (AD) and 
amyotrophic lateral sclerosis (ALS), among retired National Football League (NFL) 
players is over three times that recorded in the general population [1]. In addition, 
chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder believed to 
result from repetitive brain injury [2,3]. CTE has been recorded in association with a 
variety of physical activities including such contact sports as boxing, American 
football, ice hockey, and wrestling [4] and has also been reported in military veterans 
exposed to blast shock waves from explosive devices [5-8]. Although controversial 
[9,10], a history of mild traumatic brain injury appears to be the only risk factor 
consistently associated with CTE [4]. 
  
Clinically, the symptoms of CTE include impairment of memory and executive 
function, behavioural change, disturbances of mood, and the presence of motor 
symptoms [11,12] initially recognized two relatively distinct clinical subtypes of CTE 
presenting with either changes in behavior or mood, most frequently found in younger 
individuals, or with changes in cognition, which is more characteristic of older 
patients. Subsequently, four clinical subtypes of the disease were proposed 
characterized by: (1) changes in behaviour and mood, (2) declining cognition, (3) a 
‘mixed’ syndrome, and (4) a profound dementia [13]. In addition, in one of the largest 
studies to date of retired NFL players, Mckee et al [14] identified four stages in the 
clinical development of CTE characterized by: (1) headache, loss of attention, and 
consciousness, (2) depression, explosivity, and short-term memory loss, (3) loss of 
executive function and cognition, and (4) dementia. The stage of tau pathology 
present was related to duration of playing career, survival after retirement, and age at 
death [6].  
 
The gross neuropathology of CTE frequently overlaps with that of common 
neurodegenerative disease such as AD [4]. CTE cases exhibit reduced gray matter 
volume in several brain regions, most prominently affecting frontal and anterior 
temporal lobes and often associated with enlargement of the lateral and third 
ventricles [6,14]. A spectrum of tau-imunoreactive pathology is present which varies 
from focal, perivascular neurofibrillary tangles (NFT) in frontal cortex [15] to a more 
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widespread and severe tauopathy affecting temporal lobe, limbic system, and the 
striato-nigral system [6]. The isoform profile and phosphorylation state of tau in CTE 
is similar to that of AD in that both three-repeat (3R) and four-repeat (4R) tau are 
present in equal ratios [16]. NFT and neuropil threads (NT) can be observed in 
affected areas together with comorbid AD neuropathologic change (ADNC), viz. -
amyloid neuritic plaques (NP) [17,18], and astrocytic tangles (AT) [11,19]. In 
addition, the presence of dot-like lesions (DL) was reported in CTE by McKee et al 
[14] resembling the argyrophilic grains (AG) commonly observed in several 
conditions including argyrophilic grain disease (AGD) [21-24], Alzheimer’s disease 
(AD) [25], and cognitively normal aged brains [26,27] but have not been investigated 
to date in CTE. Oligodendroglial inclusions (GI), abnormally enlarged neurons (EN), 
and vacuolation have also been recorded in several tauopathies and may also be 
present in CTE. In addition to tau and -amyloid pathology, transactive response 
(TAR) DNA-binding protein of 43kDa (TDP-43)-immunoreactive pathology 
[11,15,19] has been observed in a significant number of CTE cases as neuronal 
cytoplasmic inclusions (NCI) and dot-like structures with a distribution similar to that 
of frontotemporal dementia with TDP-43-immunoreactive inclusions [28,29].  
 
The present study quantified tau-immunoreactive NFT, NT, DL, NP, AT, and GI 
together with vacuoles, neurons, and EN in regions of frontal and temporal lobe and 
in the SN of 11 cases of CTE with the following specific objectives: (1) to compare 
densities of pathological changes among regions, (2) to determine the relative 
abundance of neuronal and glial pathologies, (3) to determine the pathological 
importance of GR, EN, and vacuoles, (4) to compare densities of the pathology in 
crests/sides of gyri within the depths of the sulci, and (5) using principal components 
analysis (PCA) [29], to determine the degree of heterogeneity among cases and the 
most important sources of neuropathological variation.  In addition, as ADNC co-
pathology is commonly reported in CTE [11,19], the CTE data were compared with 
ADNC cases not associated with CTE, but with a similar degree of AD pathology 
[30]. 
 
Materials and Methods 
 
Cases 
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CTE cases (n = 11, mean age 70 years, SD = 6.42) and ADNC cases not associated 
with CTE (n = 7, mean age 79 years, SD = 8.83) (Table 1) were obtained from the 
Boston University Alzheimer’s Disease Center CTE Program Brain Bank, Boston 
University School of Medicine, Boston, MA, USA. ADNC cases without CTE had a 
higher average age and SD compared with the CTE cases but a similar pathology, 
National Institute on Aging-Alzheimer’s (NIA-AA) association guidelines ‘ABC’ 
scores equating to ‘not AD’ - ‘intermediate’ probability of AD [30]. With the 
exception of one CTE case, a boxer for 26 years (Case C), all individuals had played 
American football, with career durations varying from 11-24 years. In addition, all 
subjects had suffered at least one concussion, associated with variable loss of 
consciousness; the majority of subjects having experienced multiple episodes of 
trauma during their athletic careers. One case was diagnosed as ‘pure’ CTE without 
any associated co-morbidity but the remaining cases exhibited one or more co-
pathologies most commonly ADNC (N = 7), primary age-related tauopathy (PART) 
(N = 2), hippocampal sclerosis (HS) (N = 4), TDP-43 immunoreactive pathology (N = 
8), or AGD (N = 1). Inclusion criteria for cases were according to McKee et al. 
[14,31]. The most important diagnostic criterion is the presence of abnormally 
phosphorylated tau (p-tau) aggregates in neurons, astrocytes, and cell processes and 
located around small vessels in an irregular pattern in the depths of cortical gyri. In 
addition, supportive criteria include: (1) abnormal p-tau- immunoreactive pre-NFT 
and NFT in superficial cortical laminae II/III, sector CA2 of the hippocampus, and 
proximal dendritic swellings in sector CA4, (3) abnormal p-tau aggregates in 
mammillary bodies, hypothalamic nuclei, amygdala, nucleus accumbens, midbrain 
tegmentum, nucleus basalis, substantia nigra, and locus caeruleus, (4) p-tau-
immunoreactive astrocytes at glial limitans, and (5) p-tau-immunoreactive grain-like 
or DL lesions. PART is a new neuropathological entity which describes tau pathology 
in the temporal lobe associated with aging independent of amyloid pathology [32,33]. 
Hence, cases diagnosed as CTE were also designated as having PART according to 
the following inclusion criteria: (1) a diffuse cerebral atrophy was present most severe 
in the temporal lobe, (2) NFT were present in the medial temporal lobe, hippocampus, 
and amygdala, (3) extracellular ‘ghost’ tangles were present, and (4) sparse diffuse -
amyloid deposits were present but with very few NP [32]. 
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Neuropathology 
 
All procedures performed in these studies were in accordance with the ethical 
standards of the institutional Review Board of Boston University and were carried out 
according to the 1964 Declaration of Helsinki and later amendments. After death, the 
next-of-kin provided written consent for brain removal and retention for research 
studies. Brains were fixed in ice cold periodate-lysine paraformaldehyde for at least 
two weeks, paraffin-embedded, and sections cut at 6 m. For this study, blocks were 
taken from: (1) frontal lobe to study the superior frontal gyrus (SFG) (BA 8,6), (2) 
temporal pole (BA 38,36) (3) superior temporal gyrus (STG) (BA 22), (4) medial 
temporal lobe to study entorhinal cortex (EC) (BA 28) and the amygdala, (5) HC to 
study the subiculum, sectors CA1-4, and the dentate gyrus (DG), and (6) midbrain to 
study the SN. Histologic stains included Luxol fast blue counterstained with 
hematoxylin and eosin (LHE) and a modified Bielschowsky silver impregnation. 
Immunohistochemistry was performed using the following antibodies: A42 
(AB5078P; EMD Millipore, Billerica, MA, USA; 1:2000), phosphorylated tau (AT8, 
Pierce Endogen, Rockford, IL, USA; 1:2000), and phosphorylated TDP-43 (pTDP-43, 
pS409/410 mouse monoclonal; Cosmo Bio Co, Tokyo, Japan; 1:2000). Each slide 
was scanned and subsequently visualized on a personal computer (PC) using Aperio 
Image-Scope Software (Leica Biosystems Inc. Buffalo Grove, IL, USA).  
 
Morphometric methods 
 
In each cortical region (SFG, TP, STG, EC), the densities of NFT, NT, DL, NP, AT, 
GI, vacuoles, neurons, and EN (Figs 1-4), were measured along a strip of tissue  
parallel to the pia mater, using 250 x 50 µm sample fields arranged contiguously and 
superimposed over the tau-immunoreactive image using either the draw or rectangle 
options. The sample fields were located in the upper (approximating to laminae II/III) 
cortex, the region where tau-pathology of CTE is most evident [6,34]. The short edge 
of the sample field was orientated parallel with the pia mater and aligned with 
guidelines also marked on the section. Sample fields were located first, commencing 
on the crest and extending to the upper side of the gyrus (N = 32 fields) and second, in 
the depths of the adjacent sulcus (N = 16 fields). In the HC, the histological features 
were counted in the subiculum (N = 16 fields) and in sectors CA1, CA2, CA3, and 
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CA4, (N = 16 fields for CA1, and N = 8 fields for other sectors) the short dimension 
of the sample field being aligned with the alveus to sample CA1, CA2, and CA3. 
Measurements were then continued into sector CA4 using a guideline marked on the 
section and which ceased approximately 400 µm from the DG fascia. In the DG, the 
pathology was quantified in the molecular and granule cell layer (N = 32 fields). In 
the amygdala (N = 16 fields), the fields were arranged across the maximum diameter 
of the basolateral nucleus, a region in which a particular concentration of tau 
pathology was observed. In the midbrain, fields were aligned along the lower edge of 
the crus cerebri to sample the SN as far as the corticonigral fibres (N = 16 fields). 
 
All NFT, NT, DL, AT, GI, NP, EN, surviving neurons and vacuoles were counted 
within each sample field. NT were thread-like structures some of which were 
serpiginous, while small circular structures were identified as DL (Fig 1).  AT (Fig 2) 
and GI (Fig 3) were clearly associated with glial cell nuclei, the former with larger, 
pale nuclei and the latter with small, dark nuclei, while NFT were present in the 
cytoplasm of larger cells with a distinct region of haematoxylin-positive cytoplasm. 
Neurons with an abnormally enlarged perikaryon and a nucleus displaced to the 
periphery of the cell were regarded as EN (Fig 3). Surviving neurons were identified 
as cells containing at least some stained cytoplasm in combination with larger shape 
and non-spherical outline. The number of discrete vacuoles (Fig 4) present in the 
neuropil greater than 5 m in diameter was also recorded in each sample field. It can 
be difficult to differentiate microvacuolation of the neuropil from vacuolation around 
neurons and blood vessels attributable to artifacts of processing. Hence, vacuoles 
clearly associated with such structures were not counted. 
 
Data analysis 
 
The data were analyzed by analysis of variance (ANOVA) (STATISTICA software, 
Statsoft Inc., Tulsa, OK, USA). First, mean densities of each histological feature in 
crests/sides of gyri of cortical regions were compared with those in the subiculum, 
CA sectors of the HC, amygdala, DG, and SN using two-way (cases x regions) 
ANOVA. Subsequent comparisons among brain regions were made using Tukey’s  
post-hoc test. Second, in cortical regions numerical densities of each histological 
feature were compared between gyri and sulci using two-factor, split-plot ANOVA 
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[35,]. Third, CTE/ADNC cases were compared with ADNC cases not associated with 
CTE using a two-factor repeated measures ANOVA. Fourth, to study pathological 
heterogeneity among the 11 CTE cases, the data were analysed using principal 
components analysis (PCA) [29]. Two separate analyses were carried out using the 
CTE cases as variables and the histological measurements as defining features: (1) 
PCA-1 based on the spectrum of histological features: NFT, NT, DL, AT, GI, NP, 
EN, surviving neurons, vacuoles, and (2) PCA-2 based on the tau-immunoreactive 
pathology alone. The result of a PCA is a scatter plot of the cases in relation to the 
extracted principal components (PC) in which the distance between cases reflects 
their relative similarity or dissimilarity based on the defining histological features. 
Such a plot can reveal whether neuropathological variation is continuously distributed 
or whether discrete clusters of cases are present. To correlate the location of a case on 
a PC axis with the numerical density of a specific neuropathological feature, 
correlations (Pearson’s ‘r’) were calculated between the densities of each histological 
feature of each CTE case and the factor loadings of the case relative to the PC1 and 
PC2. For example, a significant correlation between the density of a feature and PC1 
would identify that feature as important in determining the separation of cases along 
PC1. 
 
Results 
 
The numerical densities of the NFT, NT, DL and NP in each brain region, averaged 
over cases, are shown in Fig 5. Densities of the DL were 2-3 times and up to 20 times 
those of NT and NFT respectively. In a random sample of cortical DL (N = 565), 
mean diameter was 1.80 m (Median = 2 m, Mode = 2 m, range 1 - 6 m, SD = 
0.84 m). The ANOVA suggested significant differences in density of NFT (F = 4.42, 
P < 0.001), NT (F = 3.49, P < 0.001), and DL (F = 4.56, P < 0.001) among regions 
with greatest densities in sectors CA1/2 compared with most other regions. Low 
densities of NP were present in seven cases and were present largely in the temporal 
lobe. Densities of the AT (F = 1.58, P > 0.05) and GI (F = 1.10, P > 0.05) (Fig 6) were 
significantly lower than NFT and there were no statistically significant differences 
among regions. In addition, low densities of EN were present in all regions with the 
exception of the DG (Fig 7), greatest densities being observed in sector CA2, the 
amygdala, and SN (F = 6.81, P < 0.001). A significant difference in vacuolation was 
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also present among regions (F = 3.81, P < 0.001) with greatest densities in the 
temporal pole and STG. 
 
In cortical regions, there were significant differences in density of tau-
immunoreactive pathology between the crests/sides of the gyri and depths of the sulci 
(Table 2). Hence, for NFT (region x location: F = 6.64, P < 0.001) and NT (region x 
location: F= 7.11, P < 0.001), densities in sulci were greater than in gyri but only in 
the SFG whereas densities of DL were significantly greater in sulci versus gyri in all 
cortical regions studied (F = 4.06, P < 0.05). There were greater densities of AT (F = 
4.61, P < 0.05) in gyri than sulci but no significant differences in GI with location (F 
= 1.02, P > 0.05). In addition, there were no significant differences in density of EN 
between gyri and sulci (F = 0.10, P > 0.05), but the density of vacuoles was greater in 
gyri than sulci in all cortical regions (F = 10.59, P < 0.01). 
 
A comparison of the densities of histological variables in CTE and ADNC cases is 
shown in Table 3. The ANOVA suggest that only the AT (F = 5.26, P < 0.05), and NP 
(F = 13.28, P < 0.01) were significantly different between case groups across all 
regions, the density of AT being greater in CTE and NP in AD. In addition, 
significant case groups x brain region interactions suggested: (1) density of NT were 
greater in ADNC in the STG and amygdala and greater in CTE in sectors CA2 and 
CA4 (F = 2.02, P < 0.01) and (2) densities of DL were greater in CTE in the SFG and 
in sectors CA2 and CA4, (F = 2.49, P < 0.01). 
 
A PCA of the density data based on all histological variables (PCA-1) resulted in the 
extraction of two PC’s accounting in total for 80% of the variance (PC1 = 73%, PC2 
= 8%). A plot of the eleven cases in relation to PC1 and PC2 is shown in Fig 8 and 
the significant correlations between the factor loadings of the cases on the PC and 
neuropathological variables in Table 4. The cases with relatively little co-pathology, 
i.e., ‘pure’ CTE and CTE/PART are located towards the bottom right of the plot while 
cases distributed to the left and upper part of the plot exhibit a greater degree of co-
pathology. Neither cases with ADNC or TDP-43 co-pathology segregate in relation to 
PC1/2. The data suggest: (1) PC1 negatively correlates with the density of NT in 
sectors CA2/4 and the SN, and vacuolation in the DG and (2) PC1 positively 
correlates with the densities of NFT and DL in CA1 and surviving neurons in DG. In 
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addition, career length was negatively correlated with PC2 (r = -0.75, P < 0.01) but 
there were no correlations between frequency of concussions and either PC. A PCA of 
the density data based on the tau-immunoreactive pathology alone (PCA-2) also 
resulted in the extraction of two PC’s accounting for a total of 83% of the total 
variance (PC1 = 75%, PC2 = 8%). A plot of the eleven cases in relation to PC1 and 
PC2 is shown in Fig 9 and the correlations between the factor loadings of the cases on 
the PC and neuropathological variables in Table 2. The data suggest: (1) PC1 
positively correlates with the density of NFT in EC gyri and negatively correlates with 
the density of NT in sector CA2 and (2) PC1 positively correlates with the densities of 
NFT in sector CA1 and negatively correlates with DL in sector CA1. In addition, 
sporting career length was negatively correlated with PC1 (r = -0.67, P < 0.05) and 
PC2 (r = -0.75, P < 0.01). 
 
Discussion 
 
The data suggest that the eleven cases of CTE studied are characterized by the 
presence of NFT, NT, and abundant DL in multiple regions with mean densities of the 
NT and DL being significantly greater than those of NFT in all regions. Among brain 
regions: (1) NFT, NT, and DL affected most regions studied but were most abundant 
in sectors CA1 and CA2 of the HC, the SFG and DG being least affected, (2) AT and 
small numbers of GI were present but at significantly lower densities than NFT, (3) 
EN and vacuolation were present, the former at low densities in sector CA2, 
amygdala and SN and the latter in cortical regions, especially the TP and STG, and (4) 
pathological changes, especially DL and NT, were generally greater in sulci than gyri, 
whereas NFT and AT were more abundant in sulci in SFG only. EN are present at low 
density in the majority of disorders and therefore, not a specific feature of CTE. 
Hence, DL are a widespread additional feature of the pathology of CTE and these data 
suggest similarities between CTE and other disorders in which grain pathology is 
abundant, such as AGD, another tauopathy, and Parkinson’s disease dementia (PD-
Dem), a synucleinopathy [36]. Nevertheless, the range of DL size is less than the 4 - 8 
m usually quoted for grains in AGD [22] raising the question as to the whether these 
lesions are analogous to those of AGD. In addition, DI have a different distribution in 
CTe, PDD, and AGD being present at highest density in CTE ibn sectors CA1/2 of 
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ther hippocampus, CA2 in PDD [36] and the subiculum and CA 1 in AGD (R.A. 
Armstrong, unpublished data. 
 
The densities of NFT were greater in CTE than NCI in other tauopathies with 
comparable quantitative data such as Pick bodies (PB) in Pick’s disease (PiD) [37], 
and NCI in corticobasal degeneration (CBD) [38], but less than the NFT in AD [39]. 
Within the HC, densities of NFT were greatest in sectors CA1/2, lower densities 
being present in the EC, subiculum, CA1, CA4, and the DG, a similar distribution to 
that present in CBD [39]. The distribution of pathology in the HC differs between 
CTE and PiD, where characteristically large numbers of PB were present in DG 
granule cells in PiD [39]. In addition, in both AD and PSP, greater densities of NFT 
were observed in CA1 compared with CA2 [39], whereas densities were comparable 
in these regions in CTE. The distribution of the NT and DL in CTE is generally 
similar to that of the NFT with 2-3 and up to 20 times more NT and DL respectively 
than NFT. The only comparable quantitative data for such pathologies are for the 
synucleinopathy PD-Dem in which neurites and grains were present at 10 and 25 
times the density of Lewy bodies (LB) respectively [36]. The densities of glial 
inclusions were low in laminae II/III of the cortex. However, AT have been reported 
fairly widely in CTE [11] with focal aggregations around larger blood vessels and in 
lamina I, especially in the depths of the sulci [15]. 
 
A number of features of the pathology were present at higher density in the depths of 
the sulci compared with the crests and upper sides of the gyri as previously reported 
in CTE [14,15]. These differences in density were evident in all gyri studied but were 
most marked in frontal cortex where in some cases a marked perivascular distribution 
of NFT, NT, and DL was present [6,15]. This distribution is also shown by all 
morphological subtypes of A deposit in AD and could reflect greater deposition of 
A in sulci attributable to the higher density of neurons and penetrating blood vessels 
in this region [40,41]. However, there was little significant variation in neuronal 
densities between gyri and sulci in these cases, which may reflect greater neuronal 
loss in sulci. By contrast, vacuolation was less evident in the depths of the sulci 
compared with the gyri, which could reflect the more tightly packed cellular structure 
present in sulci. 
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ADNC is the most frequent co-pathology found in CTE [17,18]. Hence, comparing 
the densities of pathology in CTE in ADNC cases with and without  CTE but with 
similar overall degrees of AD pathology may enable those pathological changes more 
characteristic of CTE to be identified. Hence, although densities are low in many 
areas, the presence of AT in multiple regions appears more characteristic of CTE, 
these lesions being rare in ADNC. In addition, densities of NT and DL are 
significantly higher in frontal cortex and sectors CA2 and CA4 in CTE than ADNC. 
Conversely, the density of NP is greater in ADNC especially in the cortex. Other 
common pathological changes, such as NFT and NT have similar densities in CTE 
and ADNC suggesting they may be largely attributable to ADNC while others, such 
as EN and GI, are relatively rare and non-specific, being observed in a variety of 
disorders  
 
The results of the PCA suggest neuropathological heterogeneity among the CTE cases 
studied. The distribution of cases along PC1 positively correlates with densities of 
NFT in the EC (PCA-1) and negatively correlates with the densities of NT in sector 
CA2 (PCA-1 and PCA2) and sector CA4 (PCA-1), NT in the SN, and vacuolation in 
the DG. Hence, PC1 separates those cases with high densities of tau-immunoreactive 
pathology in the EC from those with higher densities of tau pathology in the HC. 
Similarly, PC2, although accounting for significantly less of the total variance, 
separates those cases with high densities of NFT in sector CA1 and less neuronal loss 
in the DG in the upper part of the plot from those with higher densities of DL in 
sector CA1 and greater neuronal loss in the DG. These pathological changes, 
especially along PC1 are also associated with an increase in the presence of various 
co-pathologies, most frequently AD, but also TDP-43, and HS. An interesting finding 
is the correlation between both PC1 and PC2 and career length when tau pathology 
only was included as defining variables [6]. Length of career may be a better predictor 
of resulting neuropathology as it includes sub-concussive levels of trauma and not just 
the frequency of reported concussions. In addition, recent research suggests that 
pathogenic proteins such as tau and -synuclein can be secreted from cells, enter 
other cells, and seed small intracellular aggregates within these cells [42,43]. The 
frontal lobes may be especially vulnerable to trauma and hence, could be the initial 
site of tau pathology in CTE, with subsequent spreading to other regions via cell to 
cell transport resulting in a more widespread tauopathy [42]. Separation of cases 
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along the PC could therefore be explained by variations in the anatomical pathways of 
spread of tau-immunoreactive pathology in CTE.  
 
In conclusion, the data suggest abundant and widespread tau pathology in the frontal 
and temporal lobes, and especially sectors CA1/2 in CTE. In particular, DL appear as 
a significant additional feature of the pathology. Compared with cases of ADNC 
which were not associated with CTE, the presence of AT in multiple regions and 
NT/DL pathology in sectors CA2 and CA4 appear to be a features of CTE rather than 
ADNC. By contrast, lower densities of AT and GI are present in temporal lobe and 
low densities of vacuoles and EN are present in most brain regions. There is also 
greater density of tau pathology in cortical sulci as previously reported. The eleven 
cases are neuropathologically heterogeneous which may result from many factors, 
including genetic diversity, other exposures, and variation in anatomical pathways 
subjected to trauma and  subsequently, in cell to cell transfer of tau.  
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Table 1. Demographic features and neuropathology features including National 
Institute on Aging-Alzheimer’s association guidelines ‘ABC’ scores of the cases 
studied. Chronic traumatic encephalopathy cases also include frequency of traumatic 
incidents (first figure frequency of reported concussions, second figure concussions 
resulting in loss of consciousness), and sporting career length  
_____________________________________________________________________ 
Case  Age*  Duration  Trauma  Career Neuropathology A  B  C 
      (yrs)   (yrs)   length  
_____________________________________________________________________ 
CTE 
A   75    10    10/2  18   CTE, ADNC,  A3 B2 C1 
HS, TDP-43 
B   70    4    10/1  11   CTE, ADNC,  A0 B2 C0 
                 TDP-43 
C   60    6    1/1  26   CTE,HS,   A0 B1 C0 
                 TDP-43 
D   65    10    -   19   CTE,ADNC,  A2 B2 C1 
                 HS,TDP-43 
E   70    8    3/0  21   CTE,TDP-43,  A0 B1 C0 
                 PART,AGD 
F   80    15    F   12   CTE,ADNC,  A2 B2 C0 
HS,TDP-43 
G   80    40    -   18   CTE,ADNC,  A3 B2 C1 
                 TDP-43 
H   70    11    50/1  17   CTE/PART  A0 B2 C0 
I   70    9    10/1  19   CTE,ADNC,  A2 B1 C1 
                 TDP-43 
J   60    8    25/1  21   CTE,ADNC,  A3 B2 C0 
                 TDP-43 
K   70    26    F   20   CTE     A0 B2 C0 
 
ADNC 
A   90    5    -   -   ADNC    A3 B2 C1 
B   70    3    -   -   ADNC/TDP-43 A2 B2 C1 
 23 
C   80    5    -   -   ADNC/AGD  A0 B1 C0 
D   85    12    -   -   ADNC/VD   A3 B2 C1 
E   90    9    -   -   ADNC/TDP-43 A2 B1 C1 
F   70    14    -   -   ADNC    A1 B2 C1 
G   70    8    -   -   ADNC    A3 B2 C1 
_____________________________________________________________________ 
Abbreviations: F = Frequent, ADNC = Alzheimer’s disease neuropathologic change, 
HS = Hippocampal sclerosis, TDP-43 = Transactive response (TAR) DNA-binding 
protein of 43kDa, PART = Primary age-related tauopathy, AGD = Argyrophilic grain 
disease, VD = Vascular disease, * Age rounded to nearest 5-year age interval to 
protect subject identities 
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Table 2. Mean densities (SE in parentheses) of tauimmunoreactive pathology (NFT, 
DN, DL, NP, AT, GI), together with abnormally enlarged neurons (EN), surviving 
neurons, and vacuoles in gyral crests/upper side of gyri and depths of sulci of various 
cortical regions (SFG = Superior frontal cortex, TP = Temporal pole, STG = Superior 
temporal gyrus, EC = Entorhinal cortex) in eleven cases of chronic traumatic 
encephalopathy. 
 
              Cortical region 
_____________________________________________________________________ 
Variable  Location  SFG    TP    STG    EC 
_____________________________________________________________________ 
NFT   Gyrus   0.59 (0.20)  1.73 (0.28)  0.95 (0.30)  1.69 (0.23) 
    Sulcus   2.64 (0.68)  1.69 (0.26)  0.96 (0.20)  1.93 (0.30) 
NT   Gyrus   1.30 (0.56)  1.96 (0.59)  1.63 (0.72)  3.39 (1.36) 
    Sulcus   8.27 (1.84)  3.01 (0.69)  2.56 (0.59)  6.20 (1.55) 
DL   Gyrus   8.45 (2.24)  20.88 (5.51) 12.58 (3.92) 22.25 (6.44) 
    Sulcus   27.43 (5.09) 28.47 (3.57) 21.53  (5.84) 50.00 (8.16) 
NP   Gyrus   0     0.002 (0.001) 0.01 (0.01)  0.01 (0.01) 
    Sulcus   0.01 (0.01)  0.02 (0.01)  0.05 (0.03)  0 
AT   Gyrus   0.11 (0.04)  0.20 (0.06)  0.15 (0.04)  0.21 (0.05) 
    Sulcus   0.28 (0.08)  0.24 (0.07)  0.18 (0.04)  0.21 (0.07) 
GI    Gyrus   0.02 (0.01)  0.01 (0.01)  0.02 (0.01)  0.01 (0.01) 
    Sulcus   0.01(0.01)  0.02 (0.01)  0.02 (0.01)  0.01 (0.01) 
EN   Gyrus   0.21 (0.04)  0.27 (0.05)  0.14 (0.03)  0.41 (0.09) 
    Sulcus   0.29 (0.07)  0.29 (0.05)  0.13 (0.03)  0.28 (0.06) 
Neurons  Gyrus   10.35 (1.00) 10.33 (1.12) 11.70 (0.81) 8.93 (1.15) 
    Sulcus   10.43 (1.16) 11.66 (0.70)   12.05 (0.79) 10.96 (1.61) 
Vacuoles Gyrus   5.24 (0.68)  6.88 (1.58)  6.40 (1.06)  4.94 (1.55) 
    Sulcus   4.19 (1.86)  4.61 (1.18)  4.27 (0.64)  3.94 (0.77) 
_____________________________________________________________________ 
Analysis of variance (ANOVA) (two-factor split-plot): NFT Region F = 1.89 (P > 
0.05, Gyrus/Sulcus F = 8.44 (P < 0.01), Interaction F = 6.64 (P < 0.001); NT Region F 
= 2.28 (P > 0.05, Gyrus/Sulcus F = 31.03 (P < 0.001), Interaction F = 7.11 (P < 
0.001); DL Region F = 3.30 (P < 0.05, Gyrus/Sulcus F = 45.62 (P < 0.001), 
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Interaction F = 4.06 (P > 0.05); AT Region F = 0.22 (P > 0.05, Gyrus/Sulcus F = 4.61 
(P < 0.05), Interaction F = 1.69 (P > 0.05); GI Region F = 0.45 (P > 0.05, 
Gyrus/Sulcus F = 1.02 (P > 0.05), Interaction F = 0.51 (P > 0.05); EN Region F = 
3.85 (P < 0.05), Gyrus/Sulcus F = 0.10 (P > 0.05), Interaction F = 2.19 (P > 0.05); 
Neurons Region F = 3.85 (P < 0.05), Gyrus/Sulcus F = 3.61 (P > 0.05), Interaction F 
= 0.81 (P > 0.05); Vacuoles  Region F = 0.37 (P > 0.05, Gyrus/Sulcus F = 10.59 (P < 
0.01), Interaction F = 0.52 (P > 0.05). 
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Table 3. Comparison of the densities of histological features (NFT = Neurofibrillary 
tangles, NT = Neuropil threads, DL = dot-like lesions, AI = Astrocytic inclusions, GI 
= Oligodendroglial inclusions, EN = abnormally enlarged neurons, N = Surviving 
neurons, V = vacuoles, NP = Neuritic plaques) in chronic traumatic encephalopathy 
(CTE) cases with those in Alzheimer’s disease neuropathologic change (ADNC) not 
associated with CTE. Data are ‘F’ ratios from two-factor repeated-measures ANOVA 
(*P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant, SFG = Superior frontal 
gyrus, AM = Amygdala) 
 
____________________________________________________________________ 
Feature  Case group   Brain region  Interaction  Post-hoc 
_____________________________________________________________________ 
NFT   0.74 ns    5.32***    1.58 ns   ns 
NT   1.82 ns    7.41***    2.02**   AD > CTE in STG,AM 
                     CTE > AD in CA2,CA4 
DL   0.78 ns    10.05***   2.49**   CTE>AD in CA2,CA4, 
                     SFG 
AT   5.26*     2.82***    1.07 ns   CTE > ADNC 
GI    0.89 ns    0.92 ns    1.08 ns   ns  
EN   0.04 ns    12.86***   1.44 ns   ns 
N    3.26 ns    23.65***   1.41 ns   ns 
V    1.54 ns    4.57*     0.70 ns   ns 
NP   13.28**    3.83***    3.82***   AD > CTE especially in
                     cortex 
_____________________________________________________________________
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Table 4. Correlations (Pearson’s ‘r’) between histological features (NFT = 
Neurofibrillary tangles, NT = Neuropil threads, DL = Grains, AT = Astrocytic 
inclusions GI = Oligodendroglial inclusions, EN = Abnormally enlarged neurons, N = 
Surviving neurons, V = Vacuolation) and the first two principal components (PC) in 
various brain regions (SFG = Superior frontal cortex, TP = Temporal pole, STG = 
Superior temporal gyrus, EC = Entorhinal cortex, G = Gyrus, CA1/2 = Sectors CA1-4 
of the hippocampus, DG = Dentate gyrus, SN = Substantia nigra) in cases of chronic 
traumatic encephalopathy ( * P < 0.05, ** P < 0.01). Only variables with at least one 
significant correlation with a PC are included 
 
         PCA-1: All variables          PCA-2: Tau pathology 
_____________________________________________________________________ 
Variable  Lesion   PC1   PC2      PC1   PC2    
_____________________________________________________________________ 
SFG (G) V     -0.47   -0.34      -0.66*  -0.34 
TP (G)  EN    0.58   0.27      0.64*   0.27   
EC (G)  NFT    0.35   0.16      0.61*   0.16     
EC (G)  GI     0.31   0.58      0.43   0.62* 
CA1   NFT    0.01   0.63*      0.23   0.61* 
CA1   DL    0.04   0.74**     0.24   0.73* 
CA2   NT    -0.79**  -0.23      -0.68*  -0.25 
CA4   NT    -0.63*  0.25      -0.48   0.23 
DG   N     -0.28   0.66*      0.31   0.64* 
DG   V     -0.62*  0.05      -0.31   0.06 
SN   NT    -0.63*  0.33      -0.59   0.30 
 
Career       -0.26   -0.75**     -0.67*  -0.75** 
length 
____________________________________________________________________ 
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Legends to figures 
 
Fig 1. Tau-immunoreactive pathology in chronic traumatic encephalopathy (Arrow = 
Neurofibrillary tangle (NFT), Star = Neuropil thread (NT), Arrow head = Dot-like 
lesion (DL), tau immunohistochemistry (AT8), haematoxylin 
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Fig 2. Cluster of astrocytic tangles (AT) (Arrow head) surrounding a blood vessel in 
the sulcus of the entorhinal cortex in chronic traumatic encephalopathy, tau 
immunohistochemistry (AT8), haematoxylin 
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Fig 3. Abnormally enlarged neurons (EN) (Arrow head) and oligodendroglial 
inclusion (GI) (Arrow) in the superior frontal cortex in chronic traumatic 
encephalopathy, tau immunohistochemistry (AT8), haematoxylin 
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Fig 4. Vacuolation of the neuropil (Arrows), in the superior frontal cortex in chronic 
traumatic encephalopathy, tau immunohistochemistry (AT8), haematoxylin 
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Fig 5. Densities of tauimmunoreactive neuronal pathology (NFT, NT, DL, NP) in 
various brain regions (SFG = Superior frontal cortex, TP = Temporal pole, STG = 
Superior temporal gyrus, EC = Entorhinal cortex, Sub = Subiculum, CA1-4 = Cornu 
ammonis sectors of the hippocampus, DG = Dentate gyrus, AM = Basolateral 
amygdala, SN = Substantia nigra) in cases of chronic traumatic encephalopathy. 
Analysis of variance (ANOVA): Two-way, (NFT F = 4.42 (P < 0.01); NT F = 3.49 (P 
< 0.001), DL F = 4.56 (P < 0.001); NP F = 0.40 (P > 0.05) 
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Fig 6. Densities of tauimmunoreactive glial pathology (AT, GI) in various brain 
regions (SFG = Superior frontal cortex, TP = Temporal pole, STG = Superior 
temporal gyrus, EC = Entorhinal cortex, Sub = Subiculum, CA1-4 = Cornu ammonis 
sectors of the hippocampus, DG = Dentate gyrus, AM = Basolateral amygdala, SN = 
Substantia nigra) in cases of chronic traumatic encephalopathy. Analysis of variance 
(ANOVA): Two-way, (AT F = 1.58 (P > 0.05); GI F = 1.10 (P > 0.05) 
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Fig 7. Densities of abnormally enlarged neurons (EN), and vacuoles (V) in various 
brain regions (SFG = Superior frontal cortex, TP = Temporal pole, STG = Superior 
temporal gyrus, EC = Entorhinal cortex, Sub = Subiculum, CA1-4 = Cornu ammonis 
sectors of the hippocampus, DG = Dentate gyrus, AM = Basolateral amygdala, SN = 
Substantia nigra) in cases of chronic traumatic encephalopathy. Analysis of variance 
(ANOVA): Two-way, (EN F = 6.81 (P < 0.001); V F = 3.81 (P < 0.001). 
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Fig 8. Principal components analysis (PCA) of eleven cases of chronic traumatic 
encephalopathy based on all histological variables (PCA-1). A plot of cases in relation 
to PC1 and PC2. The various co-morbidities are plotted in relation to each case (AD = 
Alzheimer’s disease neuropathological change, AGD = Argyrophilic grain disease, 
PART = Primary age-related tauopathy, HS = Hippocampal sclerosis, TDP = 
transactive response (TAR) DNA-binding protein of 43kDa (TDP-43)-
immunoreactive pathology)  
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Fig 9. Principal components analysis (PCA) of eleven cases of chronic traumatic 
encephalopathy based on tau-immunoreactive pathology only (NFT, NT, DL, AI, GR, 
NP) (PCA-2). A plot of cases in relation to PC1 and PC2. Duration of sporting career 
in years is plotted in relation to each case. 
 
 
